{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T05:54:55Z","timestamp":1668491695466},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Echocardiogr"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12574-022-00575-8","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T08:02:43Z","timestamp":1652947363000},"page":"201-207","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Left atrial appendage orifice dimensions in Japanese atrial fibrillation population measured by multiplane transesophageal echocardiography"],"prefix":"10.1007","volume":"20","author":[{"given":"Miho","family":"Miyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Furugen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Ashikaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshisato","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"575_CR1","doi-asserted-by":"crossref","unstructured":"Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation 2013;127:720\u201329.","DOI":"10.1161\/CIRCULATIONAHA.112.114389"},{"key":"575_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes Jr","year":"2014","unstructured":"Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"575_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha","volume":"23","author":"KP Phillips","year":"2019","unstructured":"Phillips KP, Santoso T, Sanders P, et al. Left atrial appendage closure with WATCHMAN in Asian patients: 2year outcomes from the WASP registry. IJC Heart Vasc. 2019;23: 100358. https:\/\/doi.org\/10.1016\/j.ijcha.","journal-title":"IJC Heart Vasc"},{"key":"575_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/europace\/eux274","volume":"20","author":"H Calkins","year":"2018","unstructured":"Calkins H, Hindricks G, Cappato R, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20:e1\u2013160.","journal-title":"Europace"},{"key":"575_CR5","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s10554-019-01625-6","volume":"35","author":"YY Chen","year":"2019","unstructured":"Chen YY, Zhang YH, Chen X, et al. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation. Int J Cardiovasc Imaging. 2019;35:1831\u20139.","journal-title":"Int J Cardiovasc Imaging"},{"key":"575_CR6","doi-asserted-by":"crossref","unstructured":"Aonuma K, Yamasaki H, Nakamura M, et al. Percutaneous WATCHMAN left atrial appendage closure for Japanese patients with nonvalvular atrial fibrillation at increased risk of thromboembolism. -First results from the SALUTE trial-. Circ J 2018;82:2946\u201353.","DOI":"10.1253\/circj.CJ-18-0222"},{"key":"575_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/jce.12909","volume":"27","author":"J Saw","year":"2016","unstructured":"Saw J, Fahmy P, Spencer R, et al. Comparong measuremetns of ct Angiography, TEE, and fluoroscopy of the left atrial appendage for percutaneous closure. J Cardiovasc Electrophysiol. 2016;27:414\u201322.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"575_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jcct.2017.11.012","volume":"12","author":"Xu Bo","year":"2018","unstructured":"Bo Xu, Betancor J, Sato K, et al. Computed tomography measurement of the left atrial appendage for optimal sizing of the Watchman device. J Cardiovascular Computed Tomography. 2018;12:50\u20135.","journal-title":"J Cardiovascular Computed Tomography"},{"key":"575_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0894-7317(05)80031-8","volume":"8","author":"GI Cohen","year":"1995","unstructured":"Cohen GI, White M, Sochowski RA, et al. Reference value for normal transesophageal measurements. J Am Soc Echocardiogr. 1995;8:221\u201330.","journal-title":"J Am Soc Echocardiogr"},{"key":"575_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10840-011-9638-1","volume":"34","author":"DT Walker","year":"2012","unstructured":"Walker DT, Humphries JA, Phillips KP. Anatomical analysis of the left atrial appendage using segmented, three-dimensional cardiac CT: a comparison of patients with paroxysmal and persistent forms of atrial fibrillation. J Interv Card Electrophysiol. 2012;34:173\u20139.","journal-title":"J Interv Card Electrophysiol"},{"key":"575_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.amjcard.2017.04.013","volume":"120","author":"G Huang","year":"2017","unstructured":"Huang G, Parikh PB, Malhotra A, et al. Relation of body mass index and gender to left atrial size and atrial fibrillation. Am J Cardiol. 2017;120:218\u201322.","journal-title":"Am J Cardiol"},{"key":"575_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2143\/AC.57.2.2005380","volume":"57","author":"M Cemri","year":"2002","unstructured":"Cemri M, Timurkaynak T, Ozdemir M, et al. Effects of left ventricular systolic dysfunction on left atrial appendage and left atrial functions in patients with chronic nonvalvular atrial fibrillation. Acta cardiol. 2002;57:101\u20135.","journal-title":"Acta cardiol"},{"key":"575_CR13","first-page":"90","volume":"38","author":"A Bakalli","year":"2010","unstructured":"Bakalli A, Kamberi L, Pllana E, et al. The influence of left ventricular diameter on left atrial appendage size and thrombus formation in patients with dilated cardiomyopathy. Turk Kardiyol Dern Ars. 2010;38:90\u20134.","journal-title":"Turk Kardiyol Dern Ars"}],"container-title":["Journal of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-022-00575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12574-022-00575-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12574-022-00575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T07:17:23Z","timestamp":1668410243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12574-022-00575-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1007\/s12574-022-00575-8","relation":{},"ISSN":["1349-0222","1880-344X"],"issn-type":[{"value":"1349-0222","type":"print"},{"value":"1880-344X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"1 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Miho Miyoshi, Nozomi Watanabe, Tomoko Fukuda, Shun Nishino, Toshiyuki Kimura, Makoto Furugen, Keiichi Ashikaga, Naohiko Takahashi and Yoshisato Shibata declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights statement"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}